Justin Taylor - Concepedia

Author

Justin Taylor

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

J R Taylor, J S Taylor, J Taylor, J. Taylor, Jonathan J Taylor, Jones, Grant, Justin S. W. Taylor, Justin S.W. Taylor, Justin Taylor, Taylor, Justin

271

Publications

12.5K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center University of Miami Sylvester Comprehensive Cancer Center Dana-Farber Cancer Institute Harvard University

About

Justin Taylor is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	2.8K
2	Health Sciences	2	2	49
3	Natural Sciences	2	2	196
4	Biochemistry	2	2	196
5	Engineering	1	1	129

Justin Taylor

Publications

11.2K

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2021	1.2K
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Dan K. Chalker, James Chung Hang Chow, Loretta S. Davis, PubMed	1996	759
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers Michael Seiler, Akihide Yoshimi, Rachel Darman, Nature Medicine Tumor BiologyMedicineRna SplicingInduces LethalityCell Biology	2018	491
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, The Lancet Phase 1/2Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2021	432
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins Stanley Chun-Wei Lee, Heidi Dvinge, Eun Hee Kim, Nature Medicine Hematological MalignancyRna ProcessingSystems BiologyMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2016	352
Somatic mutations and cell identity linked by Genotyping of Transcriptomes Anna S. Nam, Kyu-Tae Kim, Ronan Chaligné, Nature Developmental BiologySomatic MutationsSomatic VariantSomatic Cell GeneticsMedicine	2019	320
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations Andrew M. Intlekofer, Alan H. Shih, Bo Wang, Nature Somatic VariantGeneticsDimer-interface MutationsMolecular BiologyIdh Inhibition	2018	271
Spliceosomal disruption of the non-canonical BAF complex in cancer Daichi Inoue, Guo-Liang Chew, Bo Liu, Nature Spliceosomal DisruptionMedicineCancer GeneticsCancer BiologyCell Biology	2019	227
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations Stanley Chun-Wei Lee, Khrystyna North, Eun Hee Kim, Cancer Cell Somatic VariantOncogenic AgentGeneticsConvergent Biological EffectsCancer Genetics	2018	211

Page 1